Welcome to our dedicated page for Medical Prop SEC filings (Ticker: MPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Medical Properties Trust, Inc. (NYSE: MPW) SEC filings page provides access to the company’s official regulatory disclosures as a self-advised real estate investment trust focused on net-leased hospital facilities. Formed in 2003 and incorporated in Maryland, Medical Properties Trust files reports and current disclosures with the U.S. Securities and Exchange Commission in connection with its common stock listed on the New York Stock Exchange under the symbol MPW.
Through this page, users can review key filings such as Form 10-K annual reports, which typically include detailed information on the company’s healthcare real estate portfolio, general acute, behavioral health and post-acute facilities, geographic exposure across the United States and international markets, capital structure, risk factors and management’s discussion and analysis. Form 10-Q quarterly reports provide interim updates on revenues from rent billed, straight-line rent, income from financing leases, interest and other income, as well as expenses, impairment charges, joint venture performance and balance sheet changes.
Investors can also examine Form 8-K current reports, where Medical Properties Trust discloses material events such as quarterly earnings releases, approval of a stock repurchase program, and other significant corporate actions. For example, Form 8-K filings in 2025 reference press releases announcing financial results for specific quarters and the authorization of a common stock repurchase program. In addition, filings may include exhibits with supplemental information packages and investor presentations.
Alongside traditional document access, this page highlights AI-powered tools that summarize lengthy filings, explain complex sections and surface important items such as changes in rent collections, impairment charges, financing transactions and capital allocation decisions. Users can quickly identify relevant sections of 10-Ks, 10-Qs and 8-Ks, and track how Medical Properties Trust reports on its hospital real estate portfolio, debt profile and shareholder-related actions over time.
Insider grant and ownership change at Medical Properties Trust (MPW). Larry H. Portal, SVP and Senior Advisor to the CEO, was reported as acquiring two equity awards on 09/24/2025. One grant of 59,743 common shares vests quarterly through March 31, 2028 and increased his beneficial ownership to 463,589 shares. A second performance-based grant of 25,058 shares is contingent on three-year total shareholder return (TSR) hurdles through April 14, 2028 (20% TSR = 100% payout; 40% = 200%; 60% = 300%); if earned, those shares vest in equal quarterly installments over the following year or in full upon final Compensation Committee determination, subject to continued employment. The Form 4 was filed 09/26/2025 and signed by a power of attorney.
Insider purchases and performance awards at Medical Properties Trust (MPW) The report shows that Kevin James Hanna, Senior VP, Controller & CAO, was granted and acquired a total of 84,801 shares of MPW common stock on 09/24/2025 through two separate awards: 59,743 time-vested shares that vest quarterly through March 31, 2028, and 25,058 performance-based shares tied to three-year total shareholder return (TSR) hurdles ending April 14, 2028. Following these transactions, the reporting person beneficially owns 449,231 shares in total. The performance award vests only if TSR targets (20%, 40%, 60%) are met, with potential upside up to 300% of the target award and post-performance quarterly vesting or earlier full vesting upon final committee determination.
Medical Properties Trust, Inc. filed a prospectus supplement dated August 11, 2025 establishing an at-the-market equity program to offer up to $500,000,000 of common stock (NYSE: MPW). The offering is being conducted under an equity distribution agreement with multiple investment banks that may act as agents, forward sellers or principals, and the agents may receive up to 2% in commissions. The supplement states the last reported NYSE sale price was $4.08 per share on August 8, 2025.
The company intends to contribute net proceeds to its operating partnership for general corporate purposes, including repayment of borrowings under its revolving credit and term loan facilities and acquiring healthcare properties. MPT reported a portfolio of 392 properties leased or loaned to 53 tenants as of June 30, 2025 (174 general acute care hospitals, 69 behavioral health, 128 post-acute, 21 freestanding ER/urgent care), with ~4% in development or not leased and no single property >2% of total assets. The prospectus highlights material risks: potential dilution from forward sale transactions, substantial cash payment obligations on cash settlement, uncertain U.S. federal tax treatment of cash-settled forwards (with potential REIT qualification implications), recent dividend reductions in 2024 and 2025, and ownership restrictions capped at 9.8% to preserve REIT status.
Medical Properties Trust, Inc. (MPW) reported combined quarterly results through June 30, 2025 showing growth in total assets to $15.15 billion from $14.29 billion while recording a consolidated net loss of $98.1 million for the three months and $216.1 million for the six months. Total revenues declined to $240.4 million in Q2 2025 from $266.6 million a year earlier, driven by lower rent billed and reduced income from financing leases. Interest expense rose to $129.7 million for the quarter, reflecting higher borrowing costs, while cash and cash equivalents increased to $509.8 million.
Other operating items materially affected results: non-cash fair value adjustments, impairment charges and equity investment swings produced $95.1 million of other expense in Q2 and $198.2 million for six months. The company closed $1.5 billion of USD and €1.0 billion of Euro senior secured notes due 2032 in February 2025 and used proceeds to redeem certain unsecured notes and pay down revolving borrowings, leaving net debt of $9.65 billion. The board declared dividends of $0.08 per share for the quarter ($0.16 year-to-date) after a prior $0.30 per-quarter level in 2024. Foreign currency translation produced a large $210.8 million gain in Q2, driving total comprehensive income for the quarter to $112.5 million despite the operating loss.